Correlation of Space Shuttle Landing Performance with Post-Flight Cardiovascular Dysfunction by McCluskey, R.
Source of Acquisition
NASA Johnson Space Center 	 3
Correlation of Space Shuttle Landing Performance with Post-Flight
Cardiovascular Dysfunction
Author: R McCluskey
Running Head: Shuttle Landing Performance
Abstract word count: 198
Narrative text word count: 1368
Number of references: 10
Number of tables: 1
Number of figures: 0
Key words: space flight, pilot performance, orthostasis
https://ntrs.nasa.gov/search.jsp?R=20100039484 2019-08-30T12:52:31+00:00Z
4ABSTRACT
Introduction: Microgravity induces cardiovascular adaptations resulting in orthostatic intolerance
on re-exposure to normal gravity. Orthostasis could interfere with performance of complex tasks
during the re-entry phase of Shuttle landings. This study correlated measures of Shuttle landing
performance with post-flight indicators of orthostatic intolerance. Methods: Relevant Shuttle
landing performance parameters routinely recorded at touchdown by NASA included downrange
and crossrange distances, airspeed, and vertical speed. Measures of cardiovascular changes
were calculated from operational stand tests performed in the immediate post-flight period on
mission commanders from STS-41 to STS-66. Stand test data analyzed included maximum
standing heart rate, mean increase in maximum heart rate, minimum standing systolic blood
pressure, and mean decrease in standing systolic blood pressure. Pearson correlation
coefficients were calculated with the null hypothesis that there was no statistically significant
linear correlation between stand test results and Shuttle landing performance. A correlation
coefficient? 0.5 with a p<0.05 was considered significant. Results: There were no significant
linear correlations between landing performance and measures of post-flight cardiovascular
dysfunction. Discussion: There was no evidence that post-flight cardiovascular stand test data
correlated with Shuttle landing performance. This implies that variations in landing performance
were not due to space flight-induced orthostatic intolerance.
INTRODUCTION
Space flight induces cardiovascular changes in response to microgravity, including intra-vascular
fluid loss and redistribution, cardiac deconditioning, and neuroendocrine changes (4,9,10). Return
to normal gravity may cause transient orthostatic intolerance and has been extensively studied
(1,3,5,6,7,8,10). Countermeasure protocols include in-flight exercise, fluid loading, and the use of
inflatable g-suits, and have been shown to reduce post-flight orthostasis (2,6). Post-flight
orthostasis has been recognized as possibly interfering with egress, but has not been studied in
the context of pilot performance during the landing phase. Unfortunately. access to returning
crews to study these performance and physiological changes is limited by operational constraints.
Some very limited testing can be performed by the crew during or immediately after landing, but
protective clothing, movement limitations, operational demands, and safety concerns restrict the
amount and type of testing that can be performed.
A measure of performance during landing would be desirable to gain insight into the effects of
early cardiovascular re-adaptation to gravity on human performance in general and pilot
pertormance in particular. Given limitations on access to the crew during landing, we proposed to
use the landing itself as a test of pilot performance by mission commanders, who usually
performed manual landings at end of mission, assisted by the pilots and other flight deck
crewmembers. Each landing of the Space Shuttle was carefully tracked by NASA and many
parameters were measured and recorded for analysis. Pilot performance during landing was
compared to physiological data collected after egress to determine whether pilot ability, and
landing safety, was affected by spaceflight-induced cardiovascular changes.
METHODS
This study protocol was approved by the Johnson Space Center Institutional Review Board.
Written informed consent was not required for this medical record review. There were 31 Shuttle
missions launched between STS-41 (October 1990) and STS-66 (November 1994). One mission
was excluded because the landing parameters were significantly altered for operational test
purposes. Out of 30 missions, the mission commanders' stand test results of 27 missions were
available for analysis. There were 20 commanders for 27 missions, because 7 commanders were
assigned to two missions each during this period. All 27 missions were included in the study
regardless of whether the commander had flown another mission during the study period. The
commanders were all male veteran astronauts between the ages of 39.9 and 59.6 years (mean
46.7 ±3.8 yrs). All mission commanders underwent extensive annual and preflight physical
examinations and were free of known cardiovascular disease.
Stand tests were performed on crewmembers preflight and post-flight as a medical requirement.
The first opportunity for stand testing in the immediate post-flight period was on the Crew Return
Vehicle or in the Multi-Functional Facility at Kennedy Space Center. This resulted in a 1-2 hour
delay with possible re-adaptation before testing could be performed. During this delay, some
crewmembers displayed symptoms of neurovestibular dysfunction. Fluid resuscitation or
medication were administered to the most symptomatic crewmembers. Briefly, each stand test
consisted of repeated blood pressure and heart rate measurements each minute for sixteen
minutes using a Dynamap automated blood pressure device. One supine baseline measurement
was followed by six supine measurements and ten standing measurements. Maximum standing
heart rate (mean 95 +/- 14 bpm), mean increase in maximum heart rate from supine to standing
(mean 33 +/- 19 bpm), minimum standing systolic blood pressure (mean 107 +/- 16 mmHg), and
mean decrease in minimum standing systolic blood pressure from supine to standing (mean -7
+/- 7 mmHg) were calculated from post-flight stand tests. None of the subjects demonstrated
orthostatis during pre-flight testing. Test results were stored in mission medical records and were
retrieved for this study. Stand tests were not performed on commanders after STS-66.
7Flight data for each landing were recorded and archived by Mission Operations Directorate at
Johnson Space Center. Data for airspeed and vertical speed at touchdown, and downrange and
crossrange positions at touchdown were easily extracted. Airspeed at touchdown was down-listed
at 1 Hz with an estimated system accuracy of +/- 19 KEAS at 200 KEAS. Target air speed varied
with the weight and balance of each flight, but was either 195 KEAS or 205 KEAS. Target
airspeed for each mission was provided and the difference calculated (mean 4.7 +/- 7.8 kts).
Vertical speed at touchdown was down listed at 1 Hz with an accuracy of +/- 1 fps. Target vertical
speed was -1 fps, but -2 to -3 fps was typical (mean 2 +/- 1 fps). Distance downrange at
touchdown was measured on the ground by identifying tire tracks and was estimated to have an
accuracy of +/- 1 inch. On cold nights when spin-up patches could not be positively identified,
estimated touchdown locations were computed post-flight from onboard navigation data. Target
downrange distance varied with the height over the threshold and speed at touchdown. The goal
was to touch down on target speed, so if height over the threshold and speed at touchdown were
on target, touchdown should have occurred at 2000 feet downrange. Target and measured
downrange distances were provided and the differences calculated (mean -406.8 +/- 665.9 ft).
Crossrange distance measured the distance to the left (negative) or to the right (positive) from the
center line (mean 2.0 +/- 9.5 ft).
The null hypothesis (Ho) was that there was no statistically significant linear correlation between
the stand test and flight data. Pearson's product moment correlation coefficients (r) were obtained
along with the probability (p) of the correlation (Prob > Irl under Ho: Rho=O for N=27) using SAS
v6.12. The Bonferroni-corrected significance level was p < 0.05 for alpha=0.0025. For N=27, the
level of significance for the correlation coefficient was r > 0.5 The independent variables were
maximum standing heart rate, percent mean increase in standing heart rate, minimum standing
systolic blood pressure, and percent mean decrease in standing systolic blood pressure, and
mission elapsed time. The dependent variables were downrange and crossrange distances,
airspeed at touchdown and vertical speed at touchdown, and mission elapsed time.
8RESULTS
The Pearson correlation coefficients and probabilities for stand test and flight data are listed in
Table I. None of the correlation coefficients reached the 0.5 level with a p < 0.05. The highest
correlation between stand test results and landing performance data was 0.38 (p = 0.04) for
decrease in systolic blood pressure on standing and airspeed at touchdown. Landing
performance and stand test data did not correlate with mission elapsed time.
DISCUSSION
There was no evidence of a significant linear correlation between landing performance and post-
flight measure of orthostasis, despite orthostasis being a well-documented post-flight
phenomenon. Although signs of orthostasis were observed during commanders' stand tests, the
magnitude of any orthostasis may not have been significant enough to overcome compensation
and contribute to performance changes. All commanders followed in-flight exercise protocols,
completed their fluid loading protocols prior to entry, were wearing g-suits, and were veteran
astronauts. Also, piloting was primarily a cognitive activity and the commanders were seated and
tightly focused on the flying task. In light of these findin g s; post-flight orthostasis may be primarily
a vehicle egress phenomenon, and not a concern for pilot performance after short (<18 day)
duration missions.
Mission duration did not correlate with either stand test data or landing performance. There was
no indication that landing performance represented a limiting factor in mission length, at least for
the mission durations included in this study. The lack of correlation between mission duration and
stand test results had been observed in other studies (1,3,5,7). It was likely that fluid shifts and
cardiovascular adaptation occurred early in flight and then plateaued for the duration of these
relatively short missions.
This study examined data for missions no longer than 18 days and under nominal operational and
weather conditions. While orthostasis did not appear to contribute to variations in landing
performance under these conditions, the level of compensation required to maintain performance
was not measured. Landing outside of accepted weather limits, mechanical malfunctions,
unavailability of cardiovascular countermeasures, or other conditions causing increased workload
could erode the available reserve of compensation. The current limit of 21 days for nominal
Space Shuttle missions seems to be consistent with the findings of this study, however factors
such as those listed above could have unknown effects on crew performance and ability to
counter post-flight orthostasis.
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Table I. Pearson correlation coefficients (p values) for mission commander stand test data and
Shuttle landing performance data for STS-41 - STS-66
MET	 DX	 DY	 VS	 DEAS
MET	 1 (0)
	 -0.09 (0.6)	 0.15 (0.38)	 -0.3(0.07)	 0.11 (0.51)
Minimum standing BP	 0.2 (0.24)	 -0.04 (0.81)	 0.07 (0.7)	 -0.2 (0.23)	 0.02 (0.9)
Maximum standing heart rate 	 -0.07 (0.68)	 -0.16 (0.34)	 07 (0.7)	 0.12 (0.49)	 0.17 (0.32)
Decrease BP, standing	 0.09 (0.66)	 0.34 (0.08)	 -0.03 (0.87)	 -0.12 (0.53)	 0.3B (0.04)
Increase heart rate, standing	 0.11 (0.58)
	
0.11 (.57)	 0.35 (0.08)	 0.19 (0.35)	 -0.21 (0.29)
(MET=mission elapsed time, DX=downrange distance at touchdown, DY= crossrange distance at
touchdown, VS=vertical speed at touchdown, DEAS= estimated airspeed at touchdown)
